Repligen Corporation
RGEN
$122.31
$1.301.07%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 650.43M | 634.44M | 633.51M | 619.83M | 620.16M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 650.43M | 634.44M | 633.51M | 619.83M | 620.16M |
| Cost of Revenue | 317.73M | 315.77M | 308.99M | 315.02M | 317.52M |
| Gross Profit | 332.70M | 318.67M | 324.52M | 304.82M | 302.64M |
| SG&A Expenses | 246.98M | 238.28M | 257.55M | 237.93M | 221.70M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 608.50M | 596.79M | 607.82M | 595.05M | 580.75M |
| Operating Income | 41.93M | 37.65M | 25.69M | 24.78M | 39.41M |
| Income Before Tax | -22.79M | -27.04M | 13.44M | 25.97M | 41.85M |
| Income Tax Expenses | 193.00K | -1.52M | 21.53M | 16.49M | 18.29M |
| Earnings from Continuing Operations | -22.98 | -25.51 | -8.10 | 9.48 | 23.56 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -22.98M | -25.51M | -8.10M | 9.48M | 23.56M |
| EBIT | 41.93M | 37.65M | 25.69M | 24.78M | 39.41M |
| EBITDA | 113.38M | 107.28M | 94.22M | 91.92M | 105.67M |
| EPS Basic | -0.41 | -0.45 | -0.15 | 0.17 | 0.42 |
| Normalized Basic EPS | 0.57 | 0.51 | 0.45 | 0.44 | 0.63 |
| EPS Diluted | -0.42 | -0.46 | -0.15 | 0.16 | 0.41 |
| Normalized Diluted EPS | 0.57 | 0.51 | 0.45 | 0.44 | 0.62 |
| Average Basic Shares Outstanding | 224.08M | 223.74M | 223.50M | 223.26M | 223.08M |
| Average Diluted Shares Outstanding | 225.06M | 225.03M | 224.79M | 225.72M | 226.14M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |